Literature DB >> 34468072

YAP facilitates melanoma migration through regulation of actin-related protein 2/3 complex subunit 5 (ARPC5).

Jason W Lui1,2, Stephen P G Moore1, Lee Huang1, Kelsey Ogomori2, Yan Li3, Deborah Lang1.   

Abstract

Yes-associated protein 1 (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are transcriptional coactivators that have been implicated in driving metastasis and progression in many cancers, mainly through their transcriptional regulation of downstream targets. Although YAP and TAZ have shown redundancy in many contexts, it is still unknown whether or not this is true in melanoma. Here, we show that while both YAP and TAZ are expressed in a panel of melanoma cell lines, depletion of YAP results in decreased cell numbers, focal adhesions, and the ability to invade matrigel. Using non-biased RNA-sequencing analysis, we find that melanoma cells depleted of YAP, TAZ, or YAP/TAZ exhibit drastically different transcriptomes. We further uncover the ARP2/3 subunit ARPC5 as a specific target of YAP but not TAZ and that ARPC5 is essential for YAP-dependent maintenance of melanoma cell focal adhesion numbers. Our findings suggest that in melanoma, YAP drives melanoma progression, survival, and invasion.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ARP2/3 complex; cancer; melanoma; transcriptional coactivator; yes-associated protein (YAP)

Mesh:

Substances:

Year:  2021        PMID: 34468072      PMCID: PMC8958630          DOI: 10.1111/pcmr.13013

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  55 in total

1.  High expression of TAZ/YAP promotes the progression of malignant melanoma and affects the postoperative survival of patients.

Authors:  Qi Feng; Peng Guo; Shengjie Kang; Feifei Zhao
Journal:  Pharmazie       Date:  2018-11-01       Impact factor: 1.267

2.  Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.

Authors:  Takashi Kinoshita; Nijiro Nohata; Haruko Watanabe-Takano; Hirofumi Yoshino; Hideo Hidaka; Lisa Fujimura; Miki Fuse; Takeshi Yamasaki; Hideki Enokida; Masayuki Nakagawa; Toyoyuki Hanazawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  Int J Oncol       Date:  2012-02-29       Impact factor: 5.650

3.  The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.

Authors:  Steven W Plouffe; Kimberly C Lin; Jerrell L Moore; Frederick E Tan; Shenghong Ma; Zhen Ye; Yunjiang Qiu; Bing Ren; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2018-05-25       Impact factor: 5.157

4.  The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.

Authors:  John M Lamar; Patrick Stern; Hui Liu; Jeffrey W Schindler; Zhi-Gang Jiang; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

5.  Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65.

Authors:  Elizabeth M Morin-Kensicki; Brian N Boone; Michael Howell; Jaclyn R Stonebraker; Jeremy Teed; James G Alb; Terry R Magnuson; Wanda O'Neal; Sharon L Milgram
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

Review 6.  The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway.

Authors:  Wanjin Hong; Kun-Liang Guan
Journal:  Semin Cell Dev Biol       Date:  2012-05-29       Impact factor: 7.727

7.  FOXD3 Promotes PAX3 Expression in Melanoma Cells.

Authors:  Jennifer D Kubic; Elizabeth C Little; Rebecca S Kaiser; Kacey P Young; Deborah Lang
Journal:  J Cell Biochem       Date:  2015-09-01       Impact factor: 4.429

8.  Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP.

Authors:  Fa-Xing Yu; Jing Luo; Jung-Soon Mo; Guangbo Liu; Young Chul Kim; Zhipeng Meng; Ling Zhao; Gholam Peyman; Hong Ouyang; Wei Jiang; Jiagang Zhao; Xu Chen; Liangfang Zhang; Cun-Yu Wang; Boris C Bastian; Kang Zhang; Kun-Liang Guan
Journal:  Cancer Cell       Date:  2014-05-29       Impact factor: 31.743

Review 9.  YAP/TAZ at the Roots of Cancer.

Authors:  Francesca Zanconato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cancer Cell       Date:  2016-06-13       Impact factor: 31.743

10.  Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4.

Authors:  Francesca Zanconato; Giusy Battilana; Mattia Forcato; Letizia Filippi; Luca Azzolin; Andrea Manfrin; Erika Quaranta; Daniele Di Biagio; Gianluca Sigismondo; Vincenza Guzzardo; Pascale Lejeune; Bernard Haendler; Jeroen Krijgsveld; Matteo Fassan; Silvio Bicciato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Nat Med       Date:  2018-09-17       Impact factor: 53.440

View more
  3 in total

1.  ARPC1A is regulated by STAT3 to inhibit ferroptosis and promote prostate cancer progression.

Authors:  Junpeng Ji; Huibing Li; Wenjun Wang; Bo Yuan; Tianyu Shen
Journal:  Hum Cell       Date:  2022-07-23       Impact factor: 4.374

Review 2.  Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.

Authors:  Jérémy H Raymond; Zackie Aktary; Lionel Larue; Véronique Delmas
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

3.  A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.

Authors:  Shenglan Huang; Liying Sun; Ping Hou; Kan Liu; Jianbing Wu
Journal:  Front Immunol       Date:  2022-09-06       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.